Jean Jacques Bienaime

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Palo Alto, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Esther Cho, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Jean Jacques Bienaime

Form 4 holding Director

BIOMARIN PHARMACEUTICAL INC

Security class
Common Stock
Shares / value
247,333
Estimated value
$19,057,008
Report date
20 May 2024
Price
$77.05
Ownership
Shares held by Jean-Jacques Bienaime Family Trust
Form 4 holding Director

BIOMARIN PHARMACEUTICAL INC

Security class
Common Stock
Shares / value
100
Estimated value
$7,705
Report date
20 May 2024
Price
$77.05
Ownership
Shares held as UTMA custodian for child 1
Form 4 holding Director

BIOMARIN PHARMACEUTICAL INC

Security class
Common Stock
Shares / value
100
Estimated value
$7,705
Report date
20 May 2024
Price
$77.05
Ownership
Shares held as UTMA custodian for child 2
Form 4 holding Director

BIOMARIN PHARMACEUTICAL INC

Security class
Stock Option (Right to Buy Common Stock)
Shares / value
51,000
Estimated value
Report date
10 May 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Immunome Inc.

Security class
Director Stock Option (right to buy)
Shares / value
9,897
Estimated value
Report date
10 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

INCYTE CORP

Security class
Non Qualfied Stock Option (right to buy)
Shares / value
6,111
Estimated value
Report date
08 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

INCYTE CORP

Security class
Non-Qualified Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
26 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Jean Jacques Bienaime

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .